Setmelanotide trial data shows promise for treatment of obesity

30 Sep 2021


Clinical trial data, presented by Rhythm Pharmaceuticals at theĀ 59th Annual European Society for Paediatric Endocrinology Meeting, indicates that setmelanotide has efficacy in treating rare genetic causes of obesity.

Yahoo